Latest Strategic Partnership News

Blue Star Helium has successfully drilled the State 9 well at its Galactica helium project in Colorado, confirming natural gas flow and progressing towards production. Laboratory tests on helium and CO2 concentrations are underway as the company prepares for production tie-in.

Strickland Metals has reported a significant high-grade gold intercept at its Gradina Prospect within the Rogozna Project, Serbia, advancing its maiden resource plans.

Ioneer Ltd has announced a 308% increase in the Ore Reserve for its Rhyolite Ridge Lithium-Boron Project in Nevada, extending mine life to 95 years and confirming robust economics with low-cost lithium production and a stable boric acid revenue stream.

ReNerve Limited has entered a strategic partnership with Berkeley Biologics to develop and commercialise two new tissue-based product ranges, aiming to expand its footprint in the US surgical market by the end of 2025.

Perenti Limited has landed a significant five-year underground mining contract worth approximately AUD 1.1 billion with Endeavour Mining, expanding its footprint in Burkina Faso’s high-grade Mana gold complex.

Papyrus Australia has secured a pivotal contract with UniSA to establish a Rapid Prototyping and R&D facility, advancing its sustainable packaging technology and commercial production plans.

Amplia Therapeutics reports strong progress in its pancreatic cancer drug development, completing the ACCENT trial recruitment ahead of schedule and initiating a new US trial, while managing a $6.57 million loss for FY25.

Tamboran Resources has successfully closed the first tranche of its PIPE, raising US$38.7 million to advance its Beetaloo Basin projects, with a second tranche pending shareholder approval.

Emmerson Resources’ joint venture partner Tennant Mining has begun commercial gold production at the Nobles Project near Tennant Creek, setting the stage for potential royalty payments and future development opportunities.

Beamtree Holdings has forged a strategic alliance with the NHS Confederation to launch a pioneering healthcare analytics platform across UK NHS Trusts, marking a significant step in its international expansion.

Dimerix has activated the first clinical trial site in Japan for its pivotal Phase 3 ACTION3 study targeting FSGS, triggering a significant milestone payment from its Japanese partner FUSO Pharmaceutical.

RareX Limited has partnered with Gega Elements to develop Australia’s inaugural integrated gallium supply chain, aiming to reduce reliance on Chinese supply and boost national critical mineral resilience.